Hepatocyte xenotransplantation for treating liver disease: Review Article

Xenotransplantation

Volumn 17, Issue 3, 2010, Pages 181-187

  Bonavita, André Gustavo ^a   Quaresma, Kátia ^a   Cotta De Almeida, Vinícius ^b   Pinto, Marcelo Alves ^c   Saraiva, Roberto Magalhães ^d   Alves, Luiz Anastácio ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Laboratório de Inovações em Terapias Ensino e Bioprodutos   (Brazil)

^c Laboratório de Desenvolvimento Tecnológico em Virologia   (Brazil)

^d Funda??o Oswaldo Cruz   (Brazil)

Author keywords

Cell therapy; Hepatocyte; Liver disease; Xenotransplantation

Indexed keywords

CELL ENCAPSULATION; CELL ISOLATION; CONVALESCENCE; EXPERIMENTAL MODEL; GRAFT REJECTION; HEPATOCYTE TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER FAILURE; LIVER FUNCTION; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; TRANSGENIC PIG; XENOTRANSPLANTATION; ANIMAL; LIVER CELL; LIVER DISEASES; LIVER TRANSPLANTATION; TRANSPLANTATION; XENOGRAFT; ZOONOSES;

ANIMALS; GRAFT REJECTION; HEPATOCYTES; HUMANS; LIVER DISEASES; LIVER FAILURE; LIVER TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; ZOONOSES;

EID: 77953513726     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2010.00588.x     Document Type: Review

References (61)

1. Fisher RA, Strom SC. Human hepatocyte transplantation: worldwide results. Transplantation 2006 82: 441 449.
2. Sgroi A, Serre-Beinier V, Morel P et al. What clinical alternatives to whole liver transplantation? Current status of artificial devices and hepatocyte transplantation. Transplantation 2009 87: 457 466.
3. Fox IJ, Chowdhury JR. Hepatocyte transplantation. Am J Transplant 2004 4 (Suppl. 6 7 13.
4. Aleem KA, Parveen N, Habeeb MA et al. Journey from hepatocyte transplantation to hepatic stem cells: a novel treatment strategy for liver diseases. Indian J Med Res 2006 123: 601 614.
5. Nussler A, Konig S, Ott M et al. Present status and perspectives of cell-based therapies for liver diseases. J Hepatol 2006 45: 144 159.
6. Sharma AD, Cantz T, Vogel A et al. Murine embryonic stem cell-derived hepatic progenitor cells engraft in recipient livers with limited capacity of liver tissue formation. Cell Transplant 2008 17: 313 323.
7. Hengstler JG, Brulport M, Schormann W et al. Generation of human hepatocytes by stem cell technology: definition of the hepatocyte. Expert Opin Drug Metab Toxicol 2005 1: 61 74.
8. Yang YG, Sykes M. Xenotransplantation: current status and a perspective on the future. Nat Rev Immunol 2007 7: 519 531.
9. Mendez-Otero R, De Freitas GR, Andre C et al. Potential roles of bone marrow stem cells in stroke therapy. Regen Med 2007 2: 417 423.
10. Lee NP, Leung KW, Cheung N et al. Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma. Proteomics 2008 8: 2136 2149.
11. Navarro-Alvarez N, Soto-Gutierrez A, Kobayashi N. Stem cell research and therapy for liver disease. Curr Stem Cell Res Ther 2009 4: 141 146.
12. Tackaberry ES, Ganz PR. Xenotransplantation: assessing the unknowns. CMAJ 1998 159: 41 43.
13. Kanazawa A, Platt JL. Prospects for xenotransplantation of the liver. Semin Liver Dis 2000 20: 511 522.
14. Cattan P, Zhang B, Braet F et al. Comparison between aortic and sinusoidal liver endothelial cells as targets of hyperacute xenogeneic rejection in the pig to human combination. Transplantation 1996 62: 803 810.
15. Nagata H, Nishitai R, Shirota C et al. Prolonged survival of porcine hepatocytes in cynomolgus monkeys. Gastroenterology 2007 132: 321 329.
16. Starzl TE, Fung J, Tzakis A et al. Baboon-to-human liver transplantation. Lancet 1993 341: 65 71.
17. Rhim JA, Sandgren EP, Palmiter RD et al. Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci USA 1995 92: 4942 4946.
18. Dandri M, Burda MR, Torok E et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 2001 33: 981 988. (Pubitemid 32246649)
19. Mai G, Nguyen TH, Morel P et al. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes. Xenotransplantation 2005 12: 457 464. (Pubitemid 41499804)
20. Tsuruga Y, Kiyono T, Matsushita M et al. Establishment of immortalized human hepatocytes by introduction of HPV16 E6/E7 and hTERT as cell sources for liver cell-based therapy. Cell Transplant 2008 17: 1083 1094.
21. Totsugawa T, Yong C, Rivas-Carrillo JD et al. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with Tamoxifen-mediated self-recombination. J Hepatol 2007 47: 74 82.
22. Katchman H, Tal O, Eventov-Friedman S et al. Embryonic porcine liver as a source for transplantation: advantage of intact liver implants over isolated hepatoblasts in overcoming homeostatic inhibition by the quiescent host liver. Stem Cells 2008 26: 1347 1355.
23. Vidal I, Blanchard N, Alexandre E et al. Improved xenogenic hepatocyte implantation into nude mouse liver parenchyma with acute liver failure when followed by repeated anti-Fas antibody (Jo2) treatment. Cell Transplant 2008 17: 507 524.
24. Papagoras D, Papalois A, Tsaroucha A et al. Beneficial effect of an antibody against interleukin-2 receptor (daclizumab) in an experimental model of hepatocyte xenotransplantation. World J Gastroenterol 2007 13: 1435 1437.
25. Yamanouchi K, Zhou H, Roy-Chowdhury N et al. Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology 2009 49: 258 267.
26. Orive G, Hernandez RM, Gascon AR et al. Cell encapsulation: promise and progress. Nat Med 2003 9: 104 107.
27. Cox A, Zhong R. Current advances in xenotransplantation. Hepatobiliary Pancreat Dis Int 2005 4: 490 494.
28. Bhatti FN, Schmoeckel M, Zaidi A et al. Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc 1999 31: 958. (Pubitemid 29127760)
29. Cozzi E, Tucker AW, Langford GA et al. Characterization of pigs transgenic for human decay-accelerating factor. Transplantation 1997 64: 1383 1392.
30. Kolber-Simonds D, Lai L, Watt SR et al. Production of alpha-1,3-galactosyltransferase null pigs by means of nuclear transfer with fibroblasts bearing loss of heterozygosity mutations. Proc Natl Acad Sci USA 2004 101: 7335 7340.
31. Lai L, Kolber-Simonds D, Park KW et al. Production of alpha-1,3-galactosyltransferase knockout pigs by nuclear transfer cloning. Science 2002 295: 1089 1092.
32. Weiss EH, Lilienfeld BG, Muller S et al. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity. Transplantation 2009 87: 35 43.
33. Koch CA, Kanazawa A, Nishitai R et al. Intrinsic resistance of hepatocytes to complement-mediated injury. J Immunol 2005 174: 7302 7309.
34. Fishman JA, Patience C. Xenotransplantation: infectious risk revisited. Am J Transplant 2004 4: 1383 1390.
35. Takeuchi Y, Patience C, Magre S et al. Host range and interference studies of three classes of pig endogenous retrovirus. J Virol 1998 72: 9986 9991.
36. Paradis K, Langford G, Long Z et al. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. The XEN 111 Study Group. Science 1999 285: 1236 1241.
37. Perico N, Benigni A, Remuzzi G. Xenotransplantation in the 21st century. Blood Purif 2002 20: 45 54.
38. Fruhauf JH, Mertsching H, Giri S et al. Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells. Liver Int 2009 29: 1553 1561.
39. Meng XJ. Swine hepatitis E virus: cross-species infection and risk in xenotransplantation. Curr Top Microbiol Immunol 2003 278: 185 216.
40. Tanaka H, Yoshino H, Kobayashi E et al. Molecular investigation of hepatitis E virus infection in domestic and miniature pigs used for medical experiments. Xenotransplantation 2004 11: 503 510.
41. Hammer C, Thein E. Physiological aspects of xenotransplantation, 2001. Xenotransplantation 2002 9: 303 305.
42. Kleine M, Schrem H, Borlak J et al. Clinical versatility of porcine hepatocytes in the light of interspecies differences in cytochrome P450 regulation and expression. Xenotransplantation 2008 15: 208 217.
43. Milosevic N, Schawalder H, Maier P. Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat hepatocytes. Eur J Pharmacol 1999 368: 75 87.
44. Monshouwer M, Witkamp RF, Nijmeijer SM et al. A lipopolysaccharide- induced acute phase response in the pig is associated with a decrease in hepatic cytochrome P450-mediated drug metabolism. J Vet Pharmacol Ther 1996 19: 382 388.
45. Muntane-Relat J, Ourlin JC, Domergue J et al. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 1995 22: 1143 1153.
46. Ibrahim Z, Busch J, Awwad M et al. Selected physiologic compatibilities and incompatibilities between human and porcine organ systems. Xenotransplantation 2006 13: 488 499.
47. Baldini E, Cursio R, De SG et al. Peritoneal implantation of cryopreserved encapsulated porcine hepatocytes in rats without immunosuppression: viability and function. Transplant Proc 2008 40: 2049 2052.
48. Loven AD, Olsen AK, Friis C et al. Phase I and II metabolism and carbohydrate metabolism in cultured cryopreserved porcine hepatocytes. Chem Biol Interact 2005 155: 21 30.
49. Sarkis R, Benoist S, Honiger J et al. Transplanted cryopreserved encapsulated porcine hepatocytes are as effective as fresh hepatocytes in preventing death from acute liver failure in rats. Transplantation 2000 70: 58 64.
50. Makowka L, Rotstein LE, Falk RE et al. Allogeneic and xenogeneic hepatocyte transplantation in experimental hepatic failure. Transplantation 1980 30: 429 435.
51. Mei J, Sgroi A, Mai G et al. Improved survival of fulminant liver failure by transplantation of microencapsulated cryopreserved porcine hepatocytes in mice. Cell Transplant 2009 18: 101 110.
52. Sarkis R, Honiger J, Chafai N et al. Semiautomatic macroencapsulation of fresh or cryopreserved porcine hepatocytes maintain their ability for treatment of acute liver failure. Cell Transplant 2001 10: 601 607.
53. Benoist S, Sarkis R, Barbu V et al. Survival and functions of encapsulated porcine hepatocytes after allotransplantation or xenotransplantation without immuno-suppression. Surgery 2001 129: 606 616. (Pubitemid 32374992)
54. Stefan AM, Coulter S, Gray B et al. Xenogeneic transplantation of porcine hepatocytes into the CCl4 cirrhotic rat model. Cell Transplant 1999 8: 649 659.
55. Nagata H, Ito M, Cai J et al. Treatment of cirrhosis and liver failure in rats by hepatocyte xenotransplantation. Gastroenterology 2003 124: 422 431.
56. Sandrin MS, Vaughan HA, Dabkowski PL et al. Human naturally occurring antibodies to pig xenografts. Transplant Proc 1994 26: 1392.
57. Sandrin MS, Fodor WL, Mouhtouris E et al. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995 1: 1261 1267.
58. Griesemer AD, Hirakata A, Shimizu A et al. Results of gal-knockout porcine thymokidney xenografts. Am J Transplant 2009 9: 2669 2678.
59. Kamano C, Vagefi PA, Kumagai N et al. Vascularized thymic lobe transplantation in miniature swine: thymopoiesis and tolerance induction across fully MHC-mismatched barriers. Proc Natl Acad Sci USA 2004 101: 3827 3832.
60. Nobori S, Samelson-Jones E, Shimizu A et al. Long-term acceptance of fully allogeneic cardiac grafts by cotransplantation of vascularized thymus in miniature swine. Transplantation 2006 81: 26 35.
61. Yamada K, Shimizu A, Utsugi R et al. Thymic transplantation in miniature swine. II. Induction of tolerance by transplantation of composite thymokidneys to thymectomized recipients. J Immunol 2000 164: 3079 3086.